share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zaderej Karen L.

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Zaderej Karen L.

EyePoint Pharmaceuticals | 4：持股變動聲明-董事 Zaderej Karen L.
美股SEC公告 ·  08/22 04:05
牛牛AI助理已提取核心訊息
On August 19, 2024, Karen L. Zaderej, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a direct purchase of 12,500 shares of common stock at a price of $7.98 per share. Following this transaction, Zaderej's direct holdings in the company increased to a total of 16,500 shares. The transaction, which took place in the open market, reflects a positive investment move by Zaderej in the company's stock.
On August 19, 2024, Karen L. Zaderej, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a direct purchase of 12,500 shares of common stock at a price of $7.98 per share. Following this transaction, Zaderej's direct holdings in the company increased to a total of 16,500 shares. The transaction, which took place in the open market, reflects a positive investment move by Zaderej in the company's stock.
2024年8月19日，與EyePoint Pharmaceuticals，Inc. [EYPT]有關聯的Karen L. Zaderej以每股7.98美元的價格直接購買了12500股普通股。在此筆交易之後，Zaderej在該公司的直接持股增加到16500股。這筆交易是在開放市場上進行的，反映了Zaderej在公司股票上的積極投資舉動。
2024年8月19日，與EyePoint Pharmaceuticals，Inc. [EYPT]有關聯的Karen L. Zaderej以每股7.98美元的價格直接購買了12500股普通股。在此筆交易之後，Zaderej在該公司的直接持股增加到16500股。這筆交易是在開放市場上進行的，反映了Zaderej在公司股票上的積極投資舉動。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間